Can a herbal ointment heal leg ulcers? small study tests MEBO
NCT ID NCT01138436
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This phase 2 pilot study tested a topical ointment called MEBO on venous leg ulcers. Only 5 people took part, and they were randomly assigned to get either MEBO or standard compression bandages. The main goal was to see if the ulcer healed completely within 8 weeks. Because the study is very small, the results are not conclusive.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- MEBO wound ointment (a topical herbal ointment)
- What this could lead to
- If it works, this could point toward a new topical treatment for venous leg ulcers that is easy to apply at home.
- What could go wrong
- This is a very small pilot study with only 5 participants, so results may not apply to everyone. The ointment may not heal ulcers better than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
5 people
The number who actually took part.
- Start date
-
Nov 2010
- Finished
-
Oct 2011
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Male or female ≥18 years of age. 2. Able and willing to provide informed consent. 3. Able and willing to comply with protocol visits and procedures. 4. A full-thickness VLU that has been open continuously for ≥4 weeks and ≤1 year. Exclusion Criteria: 1. Ulcer of a non-venous hypertensive pathophysiology. 2. Known or suspected allergy to any of the components of MEBO. 3. Malignancy on target ulcer limb. 4. Received another investigational device or drug within 30 days of enrollment. 5. Non-compliance in the screening or run-in period.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Ulcers are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Center for Clinical Research, Inc.
Castro Valley, California, 94546, United States
-
University of Miami Miller School of Medicine
Miami, Florida, 33136, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Zapping a leg nerve: can a wearable device help stubborn ulcers heal?
- Wound dressings that trap microbes: scientists test a Drug-Free approach
- Light therapy put to the test for stubborn leg wounds
- A breath of relief? essential oils tested for wound care anxiety
- Stem cell shot aims to heal stubborn leg wounds
- Sound waves and gel team up to heal stubborn leg ulcers